Skip to main content
. 2016 Jan 12;7(13):15525–15538. doi: 10.18632/oncotarget.6900

Figure 5. CD68 and IL-13 based model could identify high risk and low risk population at the same TNM stage.

Figure 5

(A) Tumor stroma CD68 density, IL-13 density and union model value at different TNM stages, *P < 0.05; **P < 0.01. (B) Prognosis prediction of CD68, IL-13 and union model at different TNM stages for ESCC patients.